ProHealth Longevity Review: Is NMN Pro the Benchmark?

ProHealth Longevity is the brand most often named when someone asks which NMN is the serious one. It has been selling supplements since 1988, it is the US seller of the branded raw material Uthever NMN, and unlike most of the shelf it publishes an actual product-specific lab report you can open and read. That combination is why roundups keep calling NMN Pro the benchmark, and it is why this review takes the brand seriously rather than lumping it in with the dozens of unmarked NMN bottles.

But "the best-documented NMN" is a claim about a low bar, and the documentation turns out to be thinner and more interested than the storefront suggests. Everything below was read in a browser on August 30, 2026 on ProHealth's own pages, and the lab report and the clinical trial were both opened and read in full.

What ProHealth Longevity actually sells

The NMN line runs on Uthever NMN, a branded β-nicotinamide mononucleotide raw material. On August 30, 2026 the storefront listed NMN Pro 500 (500 mg, 30 capsules) at $42.95 one-time, or $38.66 on a 10% subscription; NMN Pro 1000 (1,000 mg per serving, 60 capsules) at $64.95; and NMN Pro Powder (100 g) at $98.95. Around those sit tablets, lozenges, liposomal versions, bulk powders up to a kilo, an NMNH line, and blends that add trans-resveratrol and TMG.

That is a wide catalog, and two of its items matter enormously for how you should read this brand — we get to them below.

For context on the compound itself rather than the seller, start with does NMN actually work? and NMN vs NR.

The uncomfortable part: what "clinically studied" is resting on

ProHealth's NMN collection page states the claim plainly: Uthever NMN "was shown to increase NAD⁺ levels by up to 38%—equivalent to reversing biological age by 12 years." The elevator version of the brand is built on that sentence. So we opened the study.

The trial is a 2022 paper in Frontiers in Aging ¹. Here is what it is:

• •66 participants, aged 40 to 65, for 60 days, taking two 150 mg capsules a day — so 300 mg daily, well below the 500 mg and 1,000 mg servings ProHealth sells most of.
• •It has one author, and that author's stated affiliation is Effepharm (Shanghai) Co., Ltd. — the company that makes Uthever NMN. The paper carries a conflict-of-interest statement to that effect.
• •What it measured was the serum NAD+/NADH ratio, not an absolute intracellular NAD+ concentration. The Uthever group's ratio rose 38% from baseline at day 60. The placebo group's ratio rose 14.3% over the same period, which tells you how much movement this measure has in it before anything is taken.
• •The other endpoints were an SF-36 quality-of-life score (6.5% vs 3.4% in placebo) and HOMA-IR.

And the part that matters most: the paper contains no biological-age measurement at all. There is no epigenetic clock, no aging biomarker panel, nothing that could produce a figure like "12 years." That number is not a finding being reported; it is an inference layered on top of a ratio, on a product page, by the company selling the product. A biomarker moving is not a birthday moving backward, and the study ProHealth cites did not test the difference. This is the single largest gap between what the marketing says and what the cited evidence contains.

None of that makes Uthever bad material. It makes the phrase "the world's first clinically studied NMN brand" much smaller than it sounds: one manufacturer-run study, one author, 66 people, a ratio, two months.

What the independent evidence does support

Strip the brand away and the underlying compound has a real, reproducible effect — one that ProHealth is entitled to claim and that does not depend on Effepharm's study at all.

Oral NMN reliably raises blood NAD+ in humans. A dose-ranging randomized trial in healthy middle-aged adults found NMN raised blood NAD+ and was well tolerated across the doses tested ². A controlled study found oral NMN safe and efficient at increasing blood NAD+ in healthy subjects ³, and a single-dose study in healthy men showed it is safely metabolized into NAD precursors ⁴. That is a genuinely better evidence base than the one ProHealth leans on, and it belongs to the molecule rather than to any seller.

What that evidence does not deliver is the felt payoff. A 2025 systematic review and meta-analysis of NMN and nicotinamide riboside found no reliable improvement in skeletal muscle mass or function when trials were pooled ⁵. The most-cited positive downstream result — improved muscle insulin sensitivity in prediabetic women ⁶ — is narrow and contested. The softer signals that exist, such as maintained walking speed and better sleep quality in older adults ⁷, are small and partly subjective. The honest sentence is the one this whole site is built around: raising NAD+ is the proven part; feeling different is not.

So when ProHealth's product page says NMN Pro "targets all 12 hallmarks of aging," treat that as a mechanism story, not a trial result. No NMN product has been shown in humans to move twelve hallmarks of aging, and the recent clinical overview of NAD+ interventions is explicit that optimal dose, route and frequency all still need large-scale study ⁸.

The lab report: better than the category, narrower than the badge

This is where ProHealth earns real credit, so let us be specific about what we found.

Behind the "View Certificate of Authenticity" link on the NMN Pro 500 page is an actual document, and it is a good one: an analytical test report from Brighton Laboratory, an ISO/IEC 17025-accredited lab, for sample "NMN Pro 500 (30 Capsules)," lot 2509142, received October 30, 2025 and issued November 3, 2025. NMN by HPLC, claim ≥500 mg per capsule, result 513.21 mg. That is product-specific, lot-specific, recent, and it over-delivers slightly on the label. Most NMN sellers publish nothing of the kind, and this is the single strongest reason to take the brand seriously — third-party verification is the buying factor that actually varies between products, as we argue in best NMN supplements.

Two honest caveats sit next to it. The page badges the product as "Triple Lab Tested" and says every product "is tested three times by independent 3rd-party labs," but the document published behind that badge is one report, from one lab, covering one analyte — NMN potency. There are no heavy-metal results and no microbiological results on it. Testing may well happen three times; what a reader can verify is one test. And the link is labeled a "Certificate of Authenticity" while the document is an analytical test report. Those are small things, but this is a brand whose whole pitch is that you can check it, so the checkable part should match the badge.

The two products this site has to flag

ProHealth does not only sell capsules. The same storefront sells, under a "Medical Prescription" header:

• •NAD+ Injection, 10 mL at 100 mg/mL (1,000 mg per vial), compounded by a US-licensed pharmacy, listed at $349 with a first-month price of $244.30.
• •NAD+ Nasal Spray, 300 mg/mL, listed at $175 with a first-month price of $122.50.

Both are marketed on speed: the injection "delivers benefits faster than other methods," the spray gives "cellular energy in seconds." Neither claim has a placebo-controlled human trial behind it. The human record for parenteral NAD+ is a pilot study that tracked the plasma and urine NAD+ metabolome during a six-hour intravenous infusion in a handful of people ⁹ — a pharmacokinetic look at where the molecule goes, not a test of whether anyone felt or functioned better. Intranasal NAD+ is thinner still. We lay out both routes in NAD+ injections: what the evidence shows and NAD+ nasal spray evidence, and the infusion route in NAD+ IV therapy evidence.

The injection page does carry a reference list, which is more than most sellers offer. But of the products on this page, the oral capsule is the one with human randomized trials behind it and the injection is the one priced five times higher. A buyer who trusts the brand because of the capsule's lab report should not carry that trust across to the syringe: the evidence does not transfer between routes, and on this storefront the price runs in the opposite direction from the evidence.

Where ProHealth is unusually straight with you

Credit where it is due, because it is rare. On the NMN collection page, in an FAQ that most brands would use to sell the upgrade, ProHealth writes that only NMN capsules have been used in human clinical studies, that a sublingual or powdered form might theoretically start absorption earlier but "nobody has data to compare the different forms," and that "liposomal NMN absorption hasn't been tested."

That is the brand telling you, on the page where it sells liposomal NMN, that the liposomal claim is untested. We have made the same argument about the format premium in liposomal NAD+ evidence and sublingual NMN vs capsules, and it is genuinely unusual to see a seller say it first. Of the NMN and NR brands reviewed on this site, that FAQ is the most candid disclosure we have quoted.

Is ProHealth Longevity worth it?

Put it together plainly:

• •What you are reliably buying: a lot-tested, ISO-accredited-lab-verified NMN capsule that delivers the milligrams it claims, from a seller that publishes the report, at $42.95 for 30 servings of 500 mg — roughly $1.43 a day at one capsule daily. Oral NMN at that dose will very likely raise your blood NAD+ ²³.
• •What you are not buying: proof of the "12 years" claim, which the cited study never measured; proof that Uthever outperforms unbranded NMN, which no head-to-head trial has tested; or proven improvements in energy, strength or aging, which pooled trials do not support ⁵.
• •What to avoid carrying over: the confidence the capsule's paperwork earns does not extend to the prescription injection or the nasal spray on the same site.

The fair verdict: if you want an NMN capsule whose milligrams are independently verified and whose seller will show you the paperwork, ProHealth Longevity is a defensible pick — and among the NMN brands we review, its published lot report is the most concrete thing on the shelf. Just buy it for the lab report, not for the "clinically studied" line, because that line rests on a 66-person study written by the ingredient's manufacturer that never measured biological age at all.

Bottom line

ProHealth Longevity does the two things this category almost never does: it names its raw material and it publishes a current, product-specific, accredited lab report showing 513.21 mg of NMN against a 500 mg claim. That is real, and it is why the brand deserves its reputation. What does not survive reading is the story wrapped around it — a single manufacturer-authored trial in 66 people, measuring a serum ratio that also rose 14.3% in the placebo arm, converted on the product page into "reversing biological age by 12 years," a quantity the paper never measured. And the same storefront sells a prescription NAD+ injection and nasal spray at multiples of the capsule's price with far less human evidence behind them. Buy the capsule for the certificate; discount the rest.

To compare it on evidence rather than marketing, see best NMN supplements and best NAD+ supplements; for other brands read on the same terms, see our Tru Niagen review, Renue By Science review, Wonderfeel Youngr review and Qualia NAD+ review; for dosing, the NAD+ dosage guide and NMN dosage by weight; and for the underlying science, the NAD+ therapy evidence pillar and the NAD+ rankings hub.

This is consumer education, not medical advice. NMN is a dietary supplement, not an FDA-approved drug, and prescription NAD+ products require a clinician. If you are pregnant, nursing, taking medication or managing a medical condition, talk to a clinician first.